Experts weigh in on how COVID vaccines may help long-haulers
• 7 min read
Why are people hesitant to trust a COVID-19 vaccine?
Vaccines are proven to reduce deaths and help end pandemics, but the historic speed that the coronavirus vaccines have been developed has made some people hesitant to take them.Spencer Platt/Getty Images
As COVID-19 vaccination access broadens across the country, some people who suffer from long COVID, also known as long-haulers, have reported relief after getting their vaccine. Now, researchers are working to understand whether a vaccine might help people with long-term symptoms and why.
Solving this mystery may unlock the secrets of long COVID and even suggest therapies for a host of similarly elusive conditions.
WLRN
Godfrey Edmond, 51, from Miami Gardens is still dealing with neuropathy and balance issues almost a year after battling COVID-19 in early March 2020.
Nova Southeastern University was awarded $4 million from the CDC to study people left with lasting symptoms after recovering from COVID-19. It ll track people like Godfrey Edmond from Miami Gardens.
Memorial Healthcare System s very first patient with COVID-19 that they re aware of anyway was 51-year-old Godfrey Edmond, from Miami Gardens.
He s technically recovered from the virus. But about 10 months later he s still affected every day by the symptoms it s left behind: Nerve damage, balance issues. I m a true living testimony. It is real. I lived it. My family has lived it and we re still dealing with it, Edmond said.